Page 58 - Brain Function News Today

Brain function. but there are questions about whether the drug actually works. >> reporter: tonight, hope for the roughly 6 million people suffering from alzheimers. the fda proving the first new drug in 18 years. it attacks the protein that builds up in the brains of alzheimers patients. this man has been taking the drug for five hears. >> my head feels clearer definitely. im not cured in any way, shape, or form. but i feel like i have more capacity, more mental capacity than i did four years a...

Chase first banking. a debit card and app for kids, and tools for you to teach them good money habits. set account alerts, savings goals, allowances and chores from your chase mobile app. all with no monthly service fee. mention this before the, break chase first banking. doctors are getting a new weapon on the war against alzheimers. the fda has just approved a new medication designed to slow down deterioration of brain function. but as nbc news correspondent

Bit more confident now. aducanumab is suitable only for those with mild alzheimers, when damage to brain function is still limited. it could take more than a year before uk regulators decide whether to approve the drug. if they do, demand here will be enormous. fergus walsh, bbc news. the us government says it has managed to recover $2.3 million worth of cryptocurrency which had been paid to hackers who shut down a major fuel pipeline last month. that was the colonial pipeline. it was hacked by ...

So to now have a medicine that can potentially slow the disease is a huge moment and will encourage scientists to redouble their efforts and find even better treatments. aldo has been back on aducanumab for six months and says hes already beginning to feel the benefits. ive noticed that im getting less confused. although its still there, its not quite as bad. and im just feeling that bit more confident now. aducanumab is suitable only for those with mild alzheimers, when damage to brain function...

This will give hope to the people who havent had any hope for a very long time. those patients and participants in my trials who are desperate to find something that helps. in recent years, over 100 promising alzheimers drugs have flopped, so to now have a medicine that can potentially slow the disease is a huge moment and will encourage scientists to redouble their efforts and find even better treatments. aldo has been back on aducanumab for six months and says hes already beginning to feel the...

Those patients and participants in my trials who are desperate to find something that helps. in recent years, over 100 promising alzheimers drugs have flopped, so to now have a medicine that can potentially slow the disease is a huge moment and will encourage scientists to redouble their efforts and find even better treatments. aldo has been back on aducanumab for six months and says hes already beginning to feel the benefits. ive noticed that im getting less confused. although its still there, ...

In recent years, over 100 promising alzheimers drugs have flopped, so to now have a medicine that can potentially slow the disease is a huge moment and will encourage scientists to redouble their efforts and find even better treatments. aldo has been back on aducanumab for six months and says hes already beginning to feel the benefits. ive noticed that im getting less confused. although its still there, its not quite as bad. and im just feeling that bit more confident now. aducanumab is suitable...

Alzheimers, but it is the first treatment to tackle the underlying mechanism which destroys brain function in this most cruel of conditions. and that alone makes this a landmark moment. the scientific reaction has been mixed, many welcoming this as a milestone, which will boost research. but others saying they believe this drug will only have marginal benefits. and it will take years yet to know just how good this drug is. patient groups here reckon that upwards of 100,000 people with early alzh...

For six months and says hes already beginning to feel the benefits. ive noticed that im getting less confused. although its still there, its not quite as bad. and im just feeling that bit more confident now. aducanumab is suitable only for those with mild alzheimers, when damage to brain function is still limited. it could take more than a year before uk regulators decide whether to approve the drug. if they do, demand here will be enormous. fergus is with me now. not all scientists are agreed o...

Moment for alzheimers disease. in recent years, over 100 promising alzheimers drugs have flopped, so to now have a medicine that can potentially slow the disease is a huge moment and will encourage scientists to redouble their efforts and find even better treatments. aldo has been back on aducanumab for six months and says hes already beginning to feel the benefits. ive noticed that im getting less confused. although its still there, its not quite as bad. and im just feeling that bit more confid...